Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01804816 · ClinicalTrials.gov registry record · NA
Acupuncture on Cardiac and Autonomic Function in Human Heart Failure
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01804816 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 14 participants.
The verdict
NCT01804816, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Acupuncture treatment may improve the cardiac function and the quality of life in heart failure patients. These effects may be related to the inhibition of sympathetic activity and/or increased vagal function. The suppression of inflammatory reaction with acupuncture treatment may also be associated with these outcomes. Specific aims include: 1. To evaluate the effect of acupuncture treatment on human cardiac sympathetic/vagal activity 2. To evaluate the effect of acupuncture treatment on cardiac function and functional capacity 3. To evaluate the general health score of the quality-of-life with acupuncture treatment 4. To explore the mechanism of acupuncture treatment on inflammation and nitrative stress in heart failure patients.
Interventions
- OTHER No Intervention
- PROCEDURE Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-05-13 |
| Est. Completion | 2021-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01804816
The ClinicalTrials.gov registry entry for NCT01804816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No Intervention is the first listed.
NCT01804816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01804816 about?
NCT01804816 is a clinical study titled "Acupuncture on Cardiac and Autonomic Function in Human Heart Failure". Acupuncture treatment may improve the cardiac function and the quality of life in heart failure patients. These effects may be related to the inhibition of sympathetic activity and/or increased vagal function. The suppression of inflammatory reaction with acupuncture treatment may also be associated...
What is the current status of trial NCT01804816?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2013-05-13. Estimated completion is 2021-12.
What interventions are being tested in trial NCT01804816?
The interventions under investigation include: No Intervention (OTHER), Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT01804816?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.